Frank Holz

Chairman and Professor, Department of Ophthalmology, University of Bonn

Frank Holz is a researcher whose many interests include the pathogenesis, prognostic factors, biomarkers and therapy of AMD, phenotyping retinal diseases using innovative imaging technologies, the development and implementation of molecular imaging for macular and retinal diseases, and understanding the cell biology of retinal pigment epithelial cells in atrophic and neovascular ocular diseases. He has also been involved in several high profile clinical trials involving innovative therapies for macular disease. Holz has made significant advances in the understanding of macular telangiectasia, including characterizing the natural history in many patients and identifying early markers of the disease, along with better imaging methods for following disease progression. For the last three decades, he has been at the forefront of clinical research using the most advanced retinal imaging modalities, and is one of the early adopters of OCT-angiography (and one of the world’s leading authorities on its use). He is Editor-in-Chief of the journal of the German Ophthalmological Society (DOG), Der Ophthalmologe, and a past president of DOG.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016